Tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma: Updated phase 1b results of SYMPHONY-1 with 22.5 months follow-up Meeting Abstract
| Authors: | Salles, G.; Park, S. I.; Phillips, T. J.; Amengual, J. E.; Andorsky, D. J.; Campbell, P.; McKay, P.; Leonard, J. P.; Chen, Y. X.; Chen, J. D.; Bannerji, R.; Kapopara, A.; Szanto, A.; Morschhauser, F. |
| Abstract Title: | Tazemetostat in combination with lenalidomide and rituximab in patients with relapsed/refractory follicular lymphoma: Updated phase 1b results of SYMPHONY-1 with 22.5 months follow-up |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3035 |
| Language: | English |
| ACCESSION: | WOS:001159740302144 |
| DOI: | 10.1182/blood-2023-179910 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
